These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19104707)

  • 1. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
    Caruntu FA; Gheorghita V
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.
    Lubel JS; Angus PW
    J Gastroenterol Hepatol; 2010 May; 25(5):864-71. PubMed ID: 20546439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
    Wiegand J; Patel K; Tillmann HL
    Hepatology; 2009 Oct; 50(4):1314; author reply 1314. PubMed ID: 19676132
    [No Abstract]   [Full Text] [Related]  

  • 4. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
    Borgniet O; Parvaz P; Bouix C; Chevallier P; Trépo C; André P; Zoulim F
    J Med Virol; 2009 Aug; 81(8):1336-42. PubMed ID: 19551826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Discussions the therapy strategy of chronic hepatitis B by analyzing the therapeutics course of a chronic hepatitis B patient].
    Yang LQ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):709-10. PubMed ID: 19785967
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B virus reactivation associated with anti-neoplastic therapy.
    Yeo W; Chan HL
    J Gastroenterol Hepatol; 2013 Jan; 28(1):31-7. PubMed ID: 23020594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serial study of detection of serum HBV-DNA in chronic hepatitis B patients with clearance of HBs antigen followed by emergence of anti-HBs antibody].
    Kato J; Hasegawa K; Hayashi N
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):569-73. PubMed ID: 12442446
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment.
    Feld JJ; Heathcote EJ
    Semin Liver Dis; 2006 May; 26(2):116-29. PubMed ID: 16673290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].
    Wang FS; Zhang JY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):164-6. PubMed ID: 19554778
    [No Abstract]   [Full Text] [Related]  

  • 11. Do guidelines preclude hepatitis B patients from receiving treatment?
    Degertekin B; Lok AS
    Hepatology; 2009 Feb; 49(2):700-1; author reply 701-2. PubMed ID: 19177583
    [No Abstract]   [Full Text] [Related]  

  • 12. Changing landscape of antiviral resistance management in chronic hepatitis B.
    Nguyen T; Locarnini S; Desmond P
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic HBV infection in patients with lymphoproliferative syndromes].
    Łapiński TW; Jaroszewicz J; Ostapczuk A; Flisiak R
    Przegl Epidemiol; 2012; 66(1):25-31. PubMed ID: 22708294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic HBV without e antigen: using HBV DNA to guide management.
    Tran T; Martin P
    Am J Gastroenterol; 2003 Oct; 98(10):2115-7. PubMed ID: 14572554
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon treatment of anti-HBe positive and HBV-DNA positive chronic hepatitis type B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    J Chemother; 1989 Jul; 1(4 Suppl):1089-91. PubMed ID: 16312784
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update.
    Tong MJ; Hsu L; Chang PW; Blatt LM
    J Gastroenterol Hepatol; 2011 May; 26(5):829-35. PubMed ID: 21214888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lamivudine treatment of a HBs antigen positive man with reactive arthritis].
    Borup C; Siboni A
    Ugeskr Laeger; 2008 Nov; 170(48):3940-1. PubMed ID: 19087731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous hepatitis B surface antigen seroclearance confers appreciably high rates except in patients with relapse of hepatitis.
    Xin YN; Xuan SY
    Hepatology; 2008 Sep; 48(3):1021-2; author reply 1022. PubMed ID: 18756479
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy.
    Kusumoto S; Tanaka Y; Mizokami M; Ueda R
    J Clin Oncol; 2011 Feb; 29(4):e100; author reply e101. PubMed ID: 21172888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.